Clinical Trials on Bladder Substitution in United Kingdom
Total 1497 results
-
Astellas Pharma Europe B.V.CompletedUnderactive BladderJapan, Poland, Germany, Netherlands, Slovakia, United Kingdom
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerSpain, United States, Canada, France, United Kingdom
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
University College, LondonCompleted
-
North Florida/South Georgia Veterans Health SystemAxcan Pharma; North Florida Foundation for Research and EducationCompletedSuperficial Bladder CancerUnited States
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); National Institute for Biomedical Imaging...TerminatedStage II Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma | Bladder Papillary Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial Carcinoma | Stage I Bladder Cancer With Carcinoma In Situ | Stage...United States
-
Fox Chase Cancer CenterTerminatedStage III Bladder Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Squamous Cell Carcinoma of the Bladder | Urethral Cancer Associated With Invasive Bladder Cancer | Stage II Bladder CancerUnited States
-
Case Comprehensive Cancer CenterWithdrawnNon-muscle Invasive Bladder Cancer (NMIBC) | Bladder Tumor (TURBT)United States
-
Sandy SrinivasGlaxoSmithKlineCompletedBladder Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUnited States
-
NYU Langone HealthWithdrawn
-
National Cancer Institute (NCI)CompletedStage III Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
University of Kansas Medical CenterRecruitingSurgery | Bladder CancerUnited States
-
Brown UniversityLifespanTerminatedBladder Cancer | Invasive Bladder CancerUnited States
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Superficial Bladder Urothelial CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedInvasive Bladder CancerUnited States
-
TengionCompletedBladder DiseaseUnited States
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
Emory UniversityOlympusCompletedBladder CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
The University of Texas Health Science Center at...TerminatedMuscle Invasive Bladder CancerUnited States
-
Uro-1 MedicalRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage III Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Stage IIIA Bladder Cancer AJCC v8 | Stage IIIB Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8United States
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
Eisai Inc.PharmaBio Development Inc.TerminatedBladder CancerUnited Kingdom, Netherlands, Spain, Germany, United States, Ukraine
-
Michael Chancellor, MDWilliam Beaumont HospitalsCompletedOveractive BladderUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJohns Hopkins University; National Institutes of Health (NIH)WithdrawnBladder Cancer | Urothelial Carcinoma | Bladder TumorUnited States
-
IpsenTerminatedOveractive BladderUnited Kingdom, Spain, Netherlands, Belgium, France, Germany, Czechia, Italy
-
UroSee CorporationUnknownBladder TumorUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
University of OklahomaCompletedRefractory Overactive BladderUnited States
-
The University of Texas Health Science Center at...CompletedInvasive Bladder Cancer Stage IIUnited States
-
MedtronicNeuroCompletedOveractive Bladder | Urgency-frequency Syndrome | Urinary Urge IncontinenceUnited States, Netherlands, Canada, United Kingdom
-
Rapamycin Holdings, Inc. dba Emtora BiosciencesNational Cancer Institute (NCI)RecruitingNon-muscle Invasive Bladder CancerUnited States
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
European Organisation for Research and Treatment...CompletedBladder CancerNetherlands, Belgium, France, Austria, United Kingdom, Israel, Italy, Turkey, Greece, Portugal, Romania
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder OveractiveCzechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
The Methodist Hospital Research InstituteCollaborating for the Advancement of Interdisciplinary Research in Benign...RecruitingOveractive Bladder | Lower Urinary Tract Symptoms | Neurogenic Bladder | Neurogenic Detrusor Overactivity | Neuro: Neurogenic BladderUnited States
-
University of WashingtonBladder Cancer Advocacy NetworkRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
University of California, DavisRecruitingOveractive Bladder Syndrome | Neuropathic BladderUnited States
-
ShionogiCompletedHead and Neck Cancer | Esophageal Cancer | Lung Cancer | Mesothelioma | Bladder CancerUnited Kingdom
-
CAMC Health SystemCompleted
-
Anchiano Therapeutics Israel Ltd.CompletedSuperficial Bladder CancerIsrael, United States
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedBladder Cancer | Urinary BladderUnited States
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
C2i GenomicsFox Chase Cancer Center; Baylor College of Medicine; New York University; The Cleveland... and other collaboratorsTerminated
-
SunovionPPD; ICON Clinical Research; Covance; Dainippon Sumitomo Pharma America; ClinPhone...CompletedOveractive Bladder Syndrome (OABS)France, United Kingdom, United States, Estonia, Germany, Latvia, Lithuania, Poland, Spain